New Indication for Weight Loss Drug Semaglutide

被引：0

作者：

Aschenbrenner, Diane S. ^{[1
,2
]}

机构：

[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA

[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA

来源：

关键词：

D O I：

10.1097/01.NAJ.0000938724.36679.23

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese.

引用

页码：19 / 19

页数：1

共 50 条

[1] Wegovy (semaglutide): a new weight loss drug for chronic weight management
Singh, Gurdeep
Krauthamer, Matthew
Bjalme-Evans, Meghan
JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 5 - 13
[2] Semaglutide for Weight Loss
Carris, Nicholas W.
Dietrich, Eric A.
ANNALS OF PHARMACOTHERAPY, 2022, 56 (02) : 224 - 226
[3] Semaglutide for weight loss
Ojeniran, Mo
Dube, Betty
Paige, Allison
Ton, Joey
Lindblad, Adrienne J.
CANADIAN FAMILY PHYSICIAN, 2021, 67 (11) : 842 - 842
[4] Semaglutide for Weight Loss?
不详
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (08)
[5] NICE recommends weight loss drug semaglutide for obese adults
Mahase, Elisabeth
BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
[6] A New Indication for Semaglutide (Wegovy)
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1701):
[7] Semaglutide for Weight Loss: Was It Worth the Weight?
Novograd, Joel
Mullally, Jaime
Frishman, William H.
CARDIOLOGY IN REVIEW, 2022, 30 (06) : 324 - 329
[8] Semaglutide (Wegovy) for Weight Loss
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1628): : 106 - 108
[9] Semaglutide (Ozempic) for Weight Loss
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1621`): : 53 - 54
[10] Semaglutide (Wegovy) for Weight Loss in Children
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1670): : 31 - 32